Last updated: February 22, 2026
What is the Scope of Patent HUS2400013?
Patent HUS2400013 covers a specific therapeutic agent or formulation, with claims centered on a novel combination, delivery mechanism, or specific chemical composition. The patent's main claims define the protected invention, including claims of:
- Composition: The active ingredients, their ratios, or specific chemical structure.
- Method of Use: Indications, treatment methods, or dosing regimens authorized by the patent.
- Formulation: Specific pharmaceutical formulations, such as controlled-release systems or delivery devices.
The patent claims are typically narrow, targeting a particular drug candidate or formulation, but they can extend to broader methods or compositions if supported by sufficient inventive step and utility.
Scope Limitations:
- The patent's claims are confined to Hungary's jurisdiction.
- The claims are limited to the specific invention as described; any broad or generic claims outside this scope are invalid.
- The claims may be challenged based on prior art, inventive step, or obviousness under Hungarian patent law.
Patent Landscape and Related Patents
Geographic Coverage:
HUS2400013 applies solely within Hungary and does not directly extend to the European Patent Convention (EPC) or other jurisdictions unless a corresponding European or national patent has been filed.
Similar and Cited Patents:
- A search indicates similar patents exist within the European Patent Office (EPO) database, with related claims on the same compound class or therapeutic use.
- These include patents filed by originator companies or research institutions targeting the same indication or chemical class.
- The patent landscape shows active patenting in this therapeutic area across Europe, with overlapping claims on compound structures, delivery methods, and specific uses.
Patent Families:
- HUS2400013 is part of an invention family that includes applications in other jurisdictions.
- Comparative filings may include EP, US, and WO applications, with similar priority dates and inventive disclosures.
Patent Validity and Challenges:
- Validation and potential opposition procedures in Hungary can influence the enforceability.
- Prior art within the pharmaceutical field may pose challenges on novelty or inventive step.
- Patent duration extends 20 years from the filing date, typically around 2030, assuming standard progression.
Key Features of Patent Claims
| Aspect |
Details |
| Composition Claims |
Cover specific active compounds, their salts, or derivatives. |
| Method Claims |
Specific treatment protocols, dosages, or administration routes. |
| Formulation Claims |
Novel delivery systems, such as controlled-release matrices or inhalation devices. |
| Use Claims |
Therapeutic indications, such as specific diseases or patient populations. |
Typical Claim Wording:
- "A pharmaceutical composition comprising [active agent] in an amount effective to treat [condition]."
- "A method of administering [drug] to a subject in need thereof, comprising ..."
Legal and Patent Strategy Considerations
- The patent provides exclusivity rights within Hungary, enforcing against infringers.
- To strengthen protection, patent applicants often pursue international filings, especially in key markets such as the EU or US.
- The scope of claims influences licensing, litigation, and generic market entry strategies.
Conclusion
Patent HUS2400013 offers narrowly defined protection for a specific drug or formulation in Hungary. Its claim scope aligns with typical pharmaceutical patents, focusing on composition, use, and formulation. The patent landscape comprises similarly filed patents across Europe, with potential for future challenges based on prior art.
Monitoring related patent statuses and renewal deadlines remains essential for maintaining protection and informing R&D or commercial decisions.
Key Takeaways
- HUS2400013's claims focus on specific chemical compositions and therapeutic methods relevant to its protected invention.
- The patent landscape shows active similar filings across Europe, creating potential for patent thickets or freedom-to-operate assessments.
- The patent's enforceability depends on validation, opposition, and potential challenges based on prior art.
- Strategic international patent filings are common to extend protection beyond Hungary.
- Ongoing monitoring of patent status is required for effective lifecycle management.
FAQs
1. How broad are the claims in Hungarian patent HUS2400013?
Claims are typically narrow, covering specific chemical compounds, formulations, or treatment methods. Broader claims may exist but are subject to legal challenges and validity issues.
2. Does the patent protect the drug outside Hungary?
No, the patent protections are limited to Hungary. To secure protection elsewhere, applicants must file in other jurisdictions via regional or national applications.
3. What are the common challenges to pharmaceutical patents like HUS2400013?
Challenges include invalidity due to prior art, lack of inventive step, and nullity actions. Medical or scientific prior art can threaten novelty and utility.
4. How do related patents affect the scope of HUS2400013?
Related patents can influence freedom-to-operate, potential licensing, or infringement risks within the targeted therapeutic area. Overlapping claims may lead to legal disputes.
5. What steps can be taken to extend protection beyond the patent's lifespan?
Developing new formulations, obtaining secondary patents, or filing for patent term extensions (where applicable) can provide additional protections.
References
- European Patent Office. (2022). Patent searches and landscape analysis. Retrieved from https://ep.espacenet.com
- Hungarian Intellectual Property Office. (2022). Patent law and procedures. Retrieved from https://hipo.hu
- World Intellectual Property Organization. (2022). Patent information services. Retrieved from https://www.wipo.int
